
PSMA PET/CT–derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617 | Radiology
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE8yaldlaDJsUFJmazRIWVZaOTNhWWRfZnQ0YV83cDFFRmR5TXN2eTB3WE5UN05KSk5MVjBKOHRUWUc2UXM1WnFRWXFPUC1QOEpWUWw2WUZJRDdwQlVySWRUYQ?oc=5" target="_blank">PSMA PET/CT–derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617 | Radiology</a>&nbsp;&nbsp;<font color="#6f6f6f">RSNA Journals</font>
